carbon monoxide has been researched along with Chronic Insomnia in 2 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, TB | 1 |
| Piper, ME | 1 |
| Smith, SS | 1 |
| Bolt, DM | 1 |
| Stein, JH | 1 |
| Fiore, MC | 1 |
| Pappenheimer, JR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| UW Quitting Using Intensive Treatment Study[NCT03176784] | Phase 4 | 1,251 participants (Actual) | Interventional | 2017-11-11 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Biochemically confirmed self-reported total abstinence from any cigarette use (even a single puff) for the seven days preceding the target follow-up day, confirmed with an exhaled carbon monoxide reading of less than or equal to 5 ppm. (NCT03176784)
Timeframe: Assessed 23 weeks after quit date
| Intervention | Participants (Count of Participants) |
|---|---|
| Varenicline + Patch Standard Duration | 74 |
| Varenicline Only Standard Duration | 66 |
| Varenicline + Patch Extended Duration | 82 |
| Varenicline Only Extended Duration | 70 |
Biochemically confirmed self-reported total abstinence from any cigarette use (even a single puff) from week 2 post-quit through week 23 post-quit, confirmed with an exhaled carbon monoxide reading of less than or equal to 5 ppm. (NCT03176784)
Timeframe: Assessed 23 weeks after quit date
| Intervention | Participants (Count of Participants) |
|---|---|
| Varenicline + Patch Standard Duration | 66 |
| Varenicline Only Standard Duration | 72 |
| Varenicline + Patch Extended Duration | 73 |
| Varenicline Only Extended Duration | 65 |
Biochemically-confirmed self-reported total abstinence from any cigarette use (even a single puff) for the seven days preceding the target follow-up day, confirmed with an exhaled carbon monoxide reading of less than or equal to 5 ppm. (NCT03176784)
Timeframe: Assessed 52 weeks after quit date
| Intervention | Participants (Count of Participants) |
|---|---|
| Varenicline + Patch Standard Duration | 74 |
| Varenicline Only Standard Duration | 79 |
| Varenicline + Patch Extended Duration | 78 |
| Varenicline Only Extended Duration | 76 |
Biochemically confirmed self-reported total abstinence from any cigarette use (even a single puff) from week 2 post-quit through week 52 post-quit, confirmed with an exhaled carbon monoxide reading of less than or equal to 5 ppm. (NCT03176784)
Timeframe: Assessed 52 weeks after quit date
| Intervention | Participants (Count of Participants) |
|---|---|
| Varenicline + Patch Standard Duration | 47 |
| Varenicline Only Standard Duration | 55 |
| Varenicline + Patch Extended Duration | 57 |
| Varenicline Only Extended Duration | 46 |
1 trial available for carbon monoxide and Chronic Insomnia
| Article | Year |
|---|---|
Effects of Combined Varenicline With Nicotine Patch and of Extended Treatment Duration on Smoking Cessation: A Randomized Clinical Trial.
Topics: Carbon Monoxide; Combined Modality Therapy; Confidence Intervals; Double-Blind Method; Female; Human | 2021 |
1 other study available for carbon monoxide and Chronic Insomnia
| Article | Year |
|---|---|
Hypoxic insomnia: effects of carbon monoxide and acclimatization.
Topics: Acclimatization; Altitude; Animals; Body Weight; Carbon Monoxide; Chronic Disease; Hemoglobins; Huma | 1984 |